Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

323 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Effectiveness of mRNA COVID-19 vaccines and hybrid immunity in preventing SARS-CoV-2 infection and symptomatic COVID-19 among adults in the United States.
Feldstein LR, Ruffin J, Wiegand RE, Borkowf CB, James-Gist J, Babu TM, Briggs-Hagen M, Chappell J, Chu HY, Englund JA, Kuntz JL, Lauring AS, Lo N, Carone M, Lockwood C, Martin ET, Midgley CM, Monto AS, Naleway AL, Ogilvie T, Saydah S, Schmidt MA, Schmitz JE, Smith N, Sohn I, Starita L, Talbot HK, Weil AA, Grijalva CG. Feldstein LR, et al. Among authors: wiegand re. J Infect Dis. 2025 Jan 8:jiaf007. doi: 10.1093/infdis/jiaf007. Online ahead of print. J Infect Dis. 2025. PMID: 39774936
Protection from COVID-19 vaccination and prior SARS-CoV-2 infection among children aged 6 months - 4 years, United States, September 2022-April 2023.
Feldstein LR, Ruffin J, Wiegand R, Grant L, Babu TM, Briggs-Hagen M, Burgess JL, Caban-Martinez AJ, Chu HY, Ellingson KD, Englund JA, Hegmann KT, Jeddy Z, Kuntz J, Lauring AS, Lutrick K, Martin ET, Mathenge C, Meece J, Midgley CM, Monto AS, Naleway AL, Newes-Adeyi G, Odame-Bamfo L, Olsho LE, Phillips AL, Rai RP, Saydah S, Smith N, Tyner H, Vaughan M, Weil AA, Yoon SK, Britton A, Gaglani M. Feldstein LR, et al. Among authors: wiegand r. J Pediatric Infect Dis Soc. 2024 Dec 5:piae121. doi: 10.1093/jpids/piae121. Online ahead of print. J Pediatric Infect Dis Soc. 2024. PMID: 39656907
Coverage with Influenza, Respiratory Syncytial Virus, and COVID-19 Vaccines Among Nursing Home Residents - National Healthcare Safety Network, United States, November 2024.
Reses HE, Segovia G, Dubendris H, Barbre K, Ananth S, Lape-Newman B, Wong E, Stillions M, Rowe T, Mothershed E, Wallender E, Twentyman E, Wiegand RE, Patel P, Benin A, Bell JM. Reses HE, et al. Among authors: wiegand re. MMWR Morb Mortal Wkly Rep. 2024 Nov 21;73(46):1052-1057. doi: 10.15585/mmwr.mm7346a2. MMWR Morb Mortal Wkly Rep. 2024. PMID: 39570790 Free PMC article.
Association of mRNA COVID-19 vaccination and reductions in Post-COVID Conditions following SARS-CoV-2 infection in a US prospective cohort of essential workers.
Mak J, Khan S, Britton A, Rose S, Gwynn L, Ellingson KD, Meece J, Feldstein L, Tyner H, Edwards L, Thiese MS, Naleway A, Gaglani M, Solle N, Burgess JL, Lamberte JM, Shea M, Hunt-Smith T, Caban-Martinez A, Porter C, Wiegand R, Rai R, Hegmann KT, Hollister J, Fowlkes A, Wesley M, Philips AL, Rivers P, Bloodworth R, Newes-Adeyi G, Olsho LEW, Yoon SK, Saydah S, Lutrick K. Mak J, et al. Among authors: wiegand r. J Infect Dis. 2024 Nov 13:jiae556. doi: 10.1093/infdis/jiae556. Online ahead of print. J Infect Dis. 2024. PMID: 39531735
Effectiveness of Bivalent mRNA Vaccines in Preventing Symptomatic SARS-CoV-2 Infection-Increasing Community Access to Testing Program, United States, January-September 2023.
Ciesla AA, Mak J, Roper LE, Fleming-Dutra KE, Smith ZR, Wiegand RE, Britton A, Miller J, Link-Gelles R. Ciesla AA, et al. Among authors: wiegand re. Influenza Other Respir Viruses. 2024 Nov;18(11):e70038. doi: 10.1111/irv.70038. Influenza Other Respir Viruses. 2024. PMID: 39522959 Free PMC article.
323 results